Unlock the Secrets of Parkinson’s: Cambridge Cognition and Fox Foundation Team Up
Cambridge Cognition, a leader in digital brain health assessment solutions, and The Michael J. Fox Foundation for Parkinson’s Disease...
Remepy Unveils $15 Million Investment for Revolutionary Drug
Remepy, a pioneer in “hybrid drugs,” has secured $15 million in funding, led by NFX and supported by several...
Ultrasound Therapy Shows Promise in Relieving Rheumatoid Arthritis
SecondWave Systems has made a breakthrough in the treatment of rheumatoid arthritisarthritis (RA) with their novel ultrasonic stimulation technology....
Liberate Medical Breakthrough: $6.5m Grant Enrolls Patients in Global Study
The PREVENT trial is a groundbreaking clinical study investigating the VentFree Respiratory Muscle Stimulator’s efficacy in reducing the duration...
Molecular Farming: Surging Global Market to 2028, Fueled by Pharmaceutical Demand
The global molecular farming market is poised to witness significant growth, expanding from $454.1 million in 2023 to a...
Akili Shifts Strategy, Delays Earnings Amid Partner Amendment
Akili, Inc. announced several corporate developments, including an amendment to its partnership with Shionogi & Co. The amended agreement...
Qlaris Bio Secures $24 Million Funding for Revolutionary Glaucoma Drug Development
Qlaris Bio, a biotechnology company specializing in ophthalmic diseases, secured $24 million in Series B financing. The round was...
Trisalus Strengthens Infusion System Growth with $50M Debt Financing
TriSalus Life Sciences recently secured a $50 million debt facility from OrbiMed. This financing aims to support TriSalus’ expansion...
c2n Diagnostics partners with Mediford for Precivity™ Alzheimer’s Blood Test Expansion in Japan
C2N Diagnostics has partnered with Mediford Corporation, a subsidiary of PHC Holdings, to enhance access to its clinical research...
Biktarvy® Label Update: Hopeful News for Pregnant Adults with HIV
The U.S. Food and Drug Administration (FDA) has approved an updated label for Biktarvy, extending its safety and efficacy...